LifeTech Scientific Heart R Muscular VSD Occluder

LifeTech Scientific Heart R Muscular VSD Occluder

LifeTech Scientific Heart R Muscular VSD Occluder
Modified Design
Self-expandable Double disc occluder made from Nitinol filament weaved struts
Shape memory effect and hyper elasticity.
PTFE membrane is delicately sewn into the V5D/PDA devices decreasing residual shunts and have good biocompatibility.
PET material sewn into ASD device increases the occlusive properties
Compliance with Three-dimensional Anatomy of Heart
Modified design parameters. Waist height and edge
Occluder morphology: more suitable for clinical needs perfect compliance with heart anatomy.
3 different types of peri-membranous VSD-device
High Rate of Immediate Occluding
Low Rate of Long-term Residual Shunt
Comply with heart anatomy morphology
High rate of immediate occulding.
Much faster and denser as endocardium growth decrease residual shunt
Minimize the occluder’s stimulation, low incidence of long-term arrhythmia Transcatheter A5D/PDAV/VSD closure with the reports over 98% successful
occlusion takes at 13 and 6 months follow-up with low adverse event risk
and no residual shunts were found.

HeartR brochure

0.00

Description

LifeTech Scientific Heart R Muscular VSD Occluder
Modified Design
Self-expandable Double disc occluder made from Nitinol filament weaved struts
Shape memory effect and hyper elasticity.
PTFE membrane is delicately sewn into the V5D/PDA devices decreasing residual shunts and have good biocompatibility.
PET material sewn into ASD device increases the occlusive properties
Compliance with Three-dimensional Anatomy of Heart
Modified design parameters. Waist height and edge
Occluder morphology: more suitable for clinical needs perfect compliance with heart anatomy.
3 different types of peri-membranous VSD-device
High Rate of Immediate Occluding
Low Rate of Long-term Residual Shunt
Comply with heart anatomy morphology
High rate of immediate occulding.
Much faster and denser as endocardium growth decrease residual shunt
Minimize the occluder’s stimulation, low incidence of long-term arrhythmia Transcatheter A5D/PDAV/VSD closure with the reports over 98% successful
occlusion takes at 13 and 6 months follow-up with low adverse event risk
and no residual shunts were found.

HeartR brochure

Additional information

Model

Option 1, Option 2, Option 3, Option 4, Option 5, Option 6, Option 7, Option 8, Option 9, Option 10, Option 11

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.